US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akebia Therapeutics

2.04

+0.02951.47%

Volume:834.08K

Turnover:1.70M

Market Cap:540.76M

PE:-12.67

High:2.07

Open:2.02

Low:2.01

Close:2.01

52wk High:4.08

52wk Low:1.52

Shares:265.15M

Float Shares:259.80M

Volume Ratio:1.41

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1610

EPS(LYR):-0.3290

ROE:-553.45%

ROA:0.88%

PB:18.50

PE(LYR):-6.20

Loading ...

Overview Company News Filings

Akebia Therapeutics Inc - Co and IRC Announce Availability of Vafseo Across All IRC Clinics

THOMSON REUTERS

Akebia Therapeutics Expands Vafseo Availability Nationwide Across IRC Dialysis Clinics

Stock Track | Akebia Therapeutics Soars 5.48% as Analysts Reaffirm Buy Ratings

Akebia Therapeutics Shares Fall After Reporting Q2 Results

MT Newswires Live

Earnings Flash (AKBA) Akebia Therapeutics Posts Q2 EPS $0.00, vs. FactSet Est of $0.02 Loss

MT Newswires Live

Akebia Therapeutics Q2 revenue smashes expectations

Stock Track | Akebia Therapeutics Plunges 20.74% Pre-market Despite Beating Q2 Earnings Estimates

Akebia Therapeutics Q2 Sales $62.472M Beat $47.637M Estimate

Akebia Therapeutics Q2 Basic EPS USD 0

THOMSON REUTERS

Akebia Therapeutics Q2 Net Income USD 247 Thousand VS. Ibes Estimate USD -4.67 Million

THOMSON REUTERS

Akebia Therapeutics Q2 Revenue USD 62.472 Million VS. Ibes Estimate USD 47.2 Million

THOMSON REUTERS

Akebia Therapeutics Inc - Total Revenues Increase to $62.5 Mln in Q2 2025

THOMSON REUTERS

Akebia Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference

Akebia Therapeutics Inc expected to post a loss of 2 cents a share - Earnings Preview

Akebia Therapeutics Launches VOCAL Trial to Assess Vafseo for Anemia in CKD Patients at DaVita Clinics

Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights

Akebia Therapeutics Inc. SVP, CFO, CBO & Treasurer Erik Ostrowski Reports Disposal of Common Shares

BRIEF-Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc

Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AKBA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AKBA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKBA\",,,,,undefined,":{"symbol":"AKBA","market":"US","secType":"STK","nameCN":"Akebia Therapeutics","latestPrice":2.0395,"timestamp":1762528789456,"preClose":2.01,"halted":0,"volume":834080,"delay":0,"floatShares":259801013,"shares":265145038,"eps":-0.161003,"marketStatus":"Trading","change":0.0295,"latestTime":"11-07 10:19:51 EST","open":2.02,"high":2.0691,"low":2.0101,"amount":1698074.69624,"amplitude":0.029353,"askPrice":2.04,"askSize":2114,"bidPrice":2.03,"bidSize":1179,"shortable":3,"etf":0,"ttmEps":-0.161003,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1762549200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1395288000000,"exchange":"NASDAQ","adjPreClose":2.01,"preHourTrading":{"tag":"盘前","latestPrice":2.04,"preClose":2.01,"latestTime":"09:29 EST","volume":39533,"amount":81914.3170703,"timestamp":1762525799999},"postHourTrading":{"tag":"盘后","latestPrice":2.12,"preClose":2.01,"latestTime":"19:57 EST","volume":325339,"amount":661801.1478,"timestamp":1762477055542},"volumeRatio":1.412242,"impliedVol":1.1418,"impliedVolPercentile":0.656},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AKBA\",,,,,undefined,":{"symbol":"AKBA","floatShares":259801013,"roa":"0.88%","roe":"-553.45%","lyrEps":-0.32904,"volumeRatio":1.412242,"shares":265145038,"dividePrice":0,"high":2.0691,"amplitude":0.029353,"preClose":2.01,"low":2.0101,"week52Low":1.52,"pbRate":"18.50","psRate":"2.65","week52High":4.0787,"institutionHeld":0,"latestPrice":2.0395,"committee":-0.283936,"eps":-0.161003,"divideRate":0,"volume":834080,"delay":0,"ttmEps":-0.161003,"open":2.02,"prevYearClose":1.9,"prevWeekClose":2.21,"prevMonthClose":2.21,"prevQuarterClose":2.73,"fiveDayClose":2.21,"twentyDayClose":2.75,"sixtyDayClose":3.29,"earningDate":1762704000000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AKBA\",params:#limit:5,,,undefined,":[{"date":"2025-11-10","symbol":"AKBA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0,"defaultRemindTime":1762765200000,"name":null,"time":"Pre-Market","dateTimestamp":1762750800000,"actualEps":null},{"market":"US","date":"2025-08-07","symbol":"AKBA","fiscalQuarterEnding":"2025/06","expectedEps":-0.02,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-05-08","symbol":"AKBA","fiscalQuarterEnding":"2025/03","expectedEps":-0.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2025-03-13","symbol":"AKBA","fiscalQuarterEnding":"2024/12","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2024-11-07","symbol":"AKBA","fiscalQuarterEnding":"2024/09","expectedEps":-0.05,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AKBA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AKBA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1745816400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AKBA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AKBA","date":"2025-11-06","current":-12.639516,"percent":0.092074,"low":-24.854622,"twenty":-7.838707,"median":-1.775386,"eighty":-1.052489,"high":-0.211374,"avg":-4.952544,"sd":5.98902,"marketCap":562107480},"quantilePoints":[{"date":"2020-11-13","current":-0.939092,"twenty":-8.857468,"median":-7.026464,"eighty":-3.574533,"marketCap":367128790},{"date":"2020-11-20","current":-1.064798,"twenty":-8.857468,"median":-7.01772,"eighty":-3.499887,"marketCap":416272014},{"date":"2020-11-27","current":-1.253356,"twenty":-8.821765,"median":-7.007116,"eighty":-3.473189,"marketCap":489986850},{"date":"2020-12-04","current":-1.138742,"twenty":-8.787206,"median":-6.976726,"eighty":-3.408003,"marketCap":445179793},{"date":"2020-12-11","current":-1.0611,"twenty":-8.749127,"median":-6.951719,"eighty":-3.358823,"marketCap":414826625},{"date":"2020-12-18","current":-1.109164,"twenty":-8.716554,"median":-6.933304,"eighty":-3.290474,"marketCap":433616682},{"date":"2020-12-24","current":-1.079587,"twenty":-8.681928,"median":-6.927215,"eighty":-3.268108,"marketCap":422053570},{"date":"2020-12-31","current":-1.03522,"twenty":-8.657724,"median":-6.916895,"eighty":-3.225565,"marketCap":404708903},{"date":"2021-01-08","current":-1.146136,"twenty":-8.640419,"median":-6.900941,"eighty":-3.203114,"marketCap":448070571},{"date":"2021-01-15","current":-1.12765,"twenty":-8.611616,"median":-6.889862,"eighty":-3.147145,"marketCap":440843626},{"date":"2021-01-22","current":-1.242264,"twenty":-8.590006,"median":-6.887038,"eighty":-3.103199,"marketCap":485650683},{"date":"2021-01-29","current":-1.197897,"twenty":-8.578712,"median":-6.87243,"eighty":-3.073127,"marketCap":468306016},{"date":"2021-02-05","current":-1.667444,"twenty":-8.55754,"median":-6.864259,"eighty":-3.025595,"marketCap":651870411},{"date":"2021-02-12","current":-1.704416,"twenty":-8.554947,"median":-6.83561,"eighty":-2.951298,"marketCap":666324301},{"date":"2021-02-19","current":-1.641563,"twenty":-8.523585,"median":-6.816637,"eighty":-2.9067,"marketCap":641752689},{"date":"2021-02-26","current":-1.385079,"twenty":-8.484659,"median":-6.795116,"eighty":-2.878147,"marketCap":531118425},{"date":"2021-03-05","current":-1.363062,"twenty":-8.452487,"median":-6.778704,"eighty":-2.797232,"marketCap":522675791},{"date":"2021-03-12","current":-1.445126,"twenty":-8.401197,"median":-6.753694,"eighty":-2.740824,"marketCap":554143790},{"date":"2021-03-19","current":-1.405095,"twenty":-8.379421,"median":-6.717948,"eighty":-2.711089,"marketCap":538793546},{"date":"2021-03-26","current":-1.264986,"twenty":-8.35908,"median":-6.690291,"eighty":-2.671922,"marketCap":485067694},{"date":"2021-04-01","current":-1.333039,"twenty":-8.345878,"median":-6.669331,"eighty":-2.636427,"marketCap":511163108},{"date":"2021-04-09","current":-1.224955,"twenty":-8.305965,"median":-6.650772,"eighty":-2.616843,"marketCap":469717451},{"date":"2021-04-16","current":-1.184923,"twenty":-8.27623,"median":-6.620695,"eighty":-2.586244,"marketCap":454367207},{"date":"2021-04-23","current":-1.280239,"twenty":-8.257153,"median":-6.609672,"eighty":-2.566382,"marketCap":490916678},{"date":"2021-04-30","current":-1.330281,"twenty":-8.225546,"median":-6.563453,"eighty":-2.512806,"marketCap":510105604},{"date":"2021-05-07","current":-1.30109,"twenty":-8.196625,"median":-6.546422,"eighty":-2.469517,"marketCap":498912064},{"date":"2021-05-14","current":-1.408135,"twenty":-8.192389,"median":-6.509526,"eighty":-2.431668,"marketCap":552397312},{"date":"2021-05-21","current":-1.424461,"twenty":-8.18714,"median":-6.483171,"eighty":-2.409581,"marketCap":558801918},{"date":"2021-05-28","current":-1.432624,"twenty":-8.114197,"median":-6.456113,"eighty":-2.378169,"marketCap":562004222},{"date":"2021-06-04","current":-1.371401,"twenty":-8.08688,"median":-6.411227,"eighty":-2.367489,"marketCap":537986947},{"date":"2021-06-11","current":-1.497929,"twenty":-8.072446,"median":-6.393567,"eighty":-2.355234,"marketCap":587622648},{"date":"2021-06-18","current":-1.502011,"twenty":-8.043642,"median":-6.364174,"eighty":-2.336325,"marketCap":589223799},{"date":"2021-06-25","current":-1.714251,"twenty":-8.043642,"median":-6.343897,"eighty":-2.293985,"marketCap":672483684},{"date":"2021-07-02","current":-1.514255,"twenty":-8.043642,"median":-6.30904,"eighty":-2.269849,"marketCap":594027254},{"date":"2021-07-09","current":-1.391809,"twenty":-8.024841,"median":-6.290938,"eighty":-2.262594,"marketCap":545992705},{"date":"2021-07-16","current":-1.265281,"twenty":-7.947574,"median":-6.269087,"eighty":-2.242056,"marketCap":496357005},{"date":"2021-07-23","current":-1.008143,"twenty":-7.892467,"median":-6.246777,"eighty":-2.214996,"marketCap":395484452},{"date":"2021-07-30","current":-1.008143,"twenty":-7.855062,"median":-6.238748,"eighty":-2.150268,"marketCap":395484452},{"date":"2021-08-06","current":-1.59636,"twenty":-7.835611,"median":-6.23017,"eighty":-2.105836,"marketCap":478232634},{"date":"2021-08-13","current":-1.468185,"twenty":-7.826507,"median":-6.218675,"eighty":-2.062502,"marketCap":439834394},{"date":"2021-08-20","current":-1.462359,"twenty":-7.826507,"median":-6.199189,"eighty":-1.966115,"marketCap":438089019},{"date":"2021-08-27","current":-1.660447,"twenty":-7.826507,"median":-6.178528,"eighty":-1.743843,"marketCap":497431755},{"date":"2021-09-03","current":-1.765317,"twenty":-7.826507,"median":-6.156377,"eighty":-1.710974,"marketCap":528848497},{"date":"2021-09-10","current":-1.677925,"twenty":-7.826507,"median":-6.122323,"eighty":-1.707303,"marketCap":502667879},{"date":"2021-09-17","current":-1.689578,"twenty":-7.8007,"median":-6.084994,"eighty":-1.685023,"marketCap":506158628},{"date":"2021-09-24","current":-1.666273,"twenty":-7.762298,"median":-6.05006,"eighty":-1.666976,"marketCap":499177129},{"date":"2021-10-01","current":-1.648795,"twenty":-7.698464,"median":-6.021957,"eighty":-1.665873,"marketCap":493941006},{"date":"2021-10-08","current":-1.637143,"twenty":-7.678682,"median":-5.953708,"eighty":-1.642969,"marketCap":490450256},{"date":"2021-10-15","current":-1.660447,"twenty":-7.667766,"median":-5.887556,"eighty":-1.642969,"marketCap":497431755},{"date":"2021-10-22","current":-1.695404,"twenty":-7.667766,"median":-5.829583,"eighty":-1.642407,"marketCap":507904002},{"date":"2021-10-29","current":-1.672099,"twenty":-7.667766,"median":-5.808825,"eighty":-1.639795,"marketCap":500922504},{"date":"2021-11-05","current":-1.713567,"twenty":-7.667766,"median":-5.766333,"eighty":-1.639795,"marketCap":512634010},{"date":"2021-11-12","current":-1.678476,"twenty":-7.667766,"median":-5.716845,"eighty":-1.637143,"marketCap":502136385},{"date":"2021-11-19","current":-1.625841,"twenty":-7.667766,"median":-5.673519,"eighty":-1.634812,"marketCap":486389948},{"date":"2021-11-26","current":-1.561509,"twenty":-7.667766,"median":-5.658136,"eighty":-1.630665,"marketCap":467144302},{"date":"2021-12-03","current":-1.473784,"twenty":-7.667766,"median":-5.617714,"eighty":-1.619858,"marketCap":440900240},{"date":"2021-12-10","current":-1.462088,"twenty":-7.667766,"median":-5.558188,"eighty":-1.607152,"marketCap":437401032},{"date":"2021-12-17","current":-1.432846,"twenty":-7.667766,"median":-5.473232,"eighty":-1.592313,"marketCap":428653011},{"date":"2021-12-23","current":-1.479633,"twenty":-7.667766,"median":-5.427976,"eighty":-1.583148,"marketCap":442649844},{"date":"2021-12-31","current":-1.321727,"twenty":-7.634897,"median":-5.375891,"eighty":-1.561675,"marketCap":395410533},{"date":"2022-01-07","current":-1.292485,"twenty":-7.598042,"median":-5.329388,"eighty":-1.549182,"marketCap":386662512},{"date":"2022-01-14","current":-1.286637,"twenty":-7.585745,"median":-5.274237,"eighty":-1.532271,"marketCap":384912908},{"date":"2022-01-21","current":-1.16967,"twenty":-7.585745,"median":-5.243819,"eighty":-1.520407,"marketCap":349920826},{"date":"2022-01-28","current":-1.117035,"twenty":-7.585745,"median":-5.163473,"eighty":-1.502011,"marketCap":334174388},{"date":"2022-02-04","current":-1.0644,"twenty":-7.585745,"median":-5.018567,"eighty":-1.491457,"marketCap":318427951},{"date":"2022-02-11","current":-1.035158,"twenty":-7.585745,"median":-4.884215,"eighty":-1.485644,"marketCap":309679931},{"date":"2022-02-18","current":-1.058551,"twenty":-7.558586,"median":-4.503469,"eighty":-1.469123,"marketCap":316678347},{"date":"2022-02-25","current":-1.280789,"twenty":-7.553667,"median":-4.379788,"eighty":-1.456609,"marketCap":383163304},{"date":"2022-03-04","current":-1.550626,"twenty":-7.519942,"median":-4.299759,"eighty":-1.450391,"marketCap":438579191},{"date":"2022-03-11","current":-1.67237,"twenty":-7.517447,"median":-4.120299,"eighty":-1.450391,"marketCap":473013095},{"date":"2022-03-18","current":-1.601887,"twenty":-7.517447,"median":-4.015809,"eighty":-1.450391,"marketCap":453077677},{"date":"2022-03-25","current":-1.550626,"twenty":-7.517447,"median":-3.953099,"eighty":-1.450391,"marketCap":438579191},{"date":"2022-04-01","current":-0.427896,"twenty":-7.517447,"median":-3.89884,"eighty":-1.44412,"marketCap":121026109},{"date":"2022-04-08","current":-0.348571,"twenty":-7.517447,"median":-3.821143,"eighty":-1.432846,"marketCap":98589702},{"date":"2022-04-14","current":-0.344854,"twenty":-7.517447,"median":-3.792906,"eighty":-1.432264,"marketCap":97538562},{"date":"2022-04-22","current":-0.302244,"twenty":-7.517447,"median":-3.771052,"eighty":-1.42299,"marketCap":85486696},{"date":"2022-04-29","current":-0.269421,"twenty":-7.501352,"median":-3.707772,"eighty":-1.408905,"marketCap":76202932},{"date":"2022-05-06","current":-0.249759,"twenty":-7.457505,"median":-3.652069,"eighty":-1.403102,"marketCap":70641880},{"date":"2022-05-13","current":-0.299052,"twenty":-7.450265,"median":-3.588781,"eighty":-1.391887,"marketCap":82443057},{"date":"2022-05-20","current":-0.219829,"twenty":-7.448512,"median":-3.511091,"eighty":-1.389939,"marketCap":60602621},{"date":"2022-05-27","current":-0.24819,"twenty":-7.448512,"median":-3.474502,"eighty":-1.380082,"marketCap":68421130},{"date":"2022-06-03","current":-0.272955,"twenty":-7.448512,"median":-3.418423,"eighty":-1.374584,"marketCap":75248560},{"date":"2022-06-10","current":-0.271357,"twenty":-7.448512,"median":-3.37596,"eighty":-1.362281,"marketCap":74808081},{"date":"2022-06-17","current":-0.227618,"twenty":-7.448512,"median":-3.305772,"eighty":-1.355257,"marketCap":62749958},{"date":"2022-06-24","current":-0.24313,"twenty":-7.399339,"median":-3.273632,"eighty":-1.345362,"marketCap":67026278},{"date":"2022-07-01","current":-0.258975,"twenty":-7.338256,"median":-3.227198,"eighty":-1.337344,"marketCap":71394366},{"date":"2022-07-08","current":-0.306442,"twenty":-7.294284,"median":-3.206796,"eighty":-1.333039,"marketCap":84480274},{"date":"2022-07-15","current":-0.280878,"twenty":-7.258055,"median":-3.160086,"eighty":-1.328452,"marketCap":77432604},{"date":"2022-07-22","current":-0.282941,"twenty":-7.232943,"median":-3.104169,"eighty":-1.321855,"marketCap":78001556},{"date":"2022-07-29","current":-0.260306,"twenty":-7.20333,"median":-3.075067,"eighty":-1.304094,"marketCap":71761432},{"date":"2022-08-05","current":-0.444522,"twenty":-7.156976,"median":-3.026565,"eighty":-1.291622,"marketCap":72620218},{"date":"2022-08-12","current":-0.465229,"twenty":-7.156398,"median":-2.951682,"eighty":-1.282961,"marketCap":76003033},{"date":"2022-08-19","current":-0.429892,"twenty":-7.156398,"median":-2.892869,"eighty":-1.26589,"marketCap":70230185},{"date":"2022-08-26","current":-0.422915,"twenty":-7.146879,"median":-2.866506,"eighty":-1.258299,"marketCap":69090324},{"date":"2022-09-02","current":-0.427641,"twenty":-7.105438,"median":-2.796766,"eighty":-1.244325,"marketCap":69862488},{"date":"2022-09-09","current":-0.489649,"twenty":-7.066075,"median":-2.747808,"eighty":-1.234247,"marketCap":79992549},{"date":"2022-09-16","current":-0.434281,"twenty":-7.026296,"median":-2.711089,"eighty":-1.224375,"marketCap":70947195},{"date":"2022-09-23","current":-0.360119,"twenty":-6.956033,"median":-2.67437,"eighty":-1.21201,"marketCap":58831569},{"date":"2022-09-30","current":-0.355843,"twenty":-6.908714,"median":-2.631531,"eighty":-1.191329,"marketCap":58132944},{"date":"2022-10-07","current":-0.337724,"twenty":-6.884958,"median":-2.613171,"eighty":-1.181763,"marketCap":55172981},{"date":"2022-10-14","current":-0.325683,"twenty":-6.864014,"median":-2.582572,"eighty":-1.171078,"marketCap":53205800},{"date":"2022-10-21","current":-0.292597,"twenty":-6.829465,"median":-2.564213,"eighty":-1.157187,"marketCap":47800650},{"date":"2022-10-28","current":-0.292597,"twenty":-6.780329,"median":-2.509134,"eighty":-1.149834,"marketCap":47800650},{"date":"2022-11-04","current":-0.320334,"twenty":-6.710671,"median":-2.462934,"eighty":-1.138742,"marketCap":49872120},{"date":"2022-11-11","current":-0.330496,"twenty":-6.689548,"median":-2.430022,"eighty":-1.132269,"marketCap":51454194},{"date":"2022-11-18","current":-0.3071,"twenty":-6.689548,"median":-2.408081,"eighty":-1.12765,"marketCap":47811745},{"date":"2022-11-25","current":-0.302491,"twenty":-6.689548,"median":-2.380617,"eighty":-1.121186,"marketCap":47094293},{"date":"2022-12-02","current":-0.342784,"twenty":-6.689548,"median":-2.364198,"eighty":-1.104088,"marketCap":53367400},{"date":"2022-12-09","current":-0.366298,"twenty":-6.689548,"median":-2.350018,"eighty":-1.093641,"marketCap":57028245},{"date":"2022-12-16","current":-0.522152,"twenty":-6.689548,"median":-2.335655,"eighty":-1.082544,"marketCap":81292844},{"date":"2022-12-23","current":-0.504192,"twenty":-6.689548,"median":-2.287402,"eighty":-1.073633,"marketCap":78496620},{"date":"2022-12-30","current":-0.681787,"twenty":-6.689548,"median":-2.270946,"eighty":-1.0644,"marketCap":106146121},{"date":"2023-01-06","current":-0.758828,"twenty":-6.689548,"median":-2.26434,"eighty":-1.057389,"marketCap":118140449},{"date":"2023-01-13","current":-0.821217,"twenty":-6.689548,"median":-2.243519,"eighty":-1.04533,"marketCap":127853647},{"date":"2023-01-20","current":-0.870726,"twenty":-6.689548,"median":-2.221578,"eighty":-1.040026,"marketCap":135561658},{"date":"2023-01-27","current":-0.791677,"twenty":-6.689548,"median":-2.150268,"eighty":-1.031,"marketCap":123254595},{"date":"2023-02-03","current":-1.165065,"twenty":-6.689548,"median":-2.122841,"eighty":-1.011752,"marketCap":181386613},{"date":"2023-02-10","current":-0.94824,"twenty":-6.689548,"median":-2.095414,"eighty":-1.010361,"marketCap":147629571},{"date":"2023-02-17","current":-1.039064,"twenty":-6.689548,"median":-2.02959,"eighty":-1.008861,"marketCap":161769783},{"date":"2023-02-24","current":-0.976696,"twenty":-6.689548,"median":-1.887666,"eighty":-1.005132,"marketCap":152059911},{"date":"2023-03-03","current":-1.142024,"twenty":-6.689548,"median":-1.800543,"eighty":-1.003608,"marketCap":177799363},{"date":"2023-03-10","current":-1.590439,"twenty":-6.689548,"median":-1.771144,"eighty":-1.003608,"marketCap":147214187},{"date":"2023-03-17","current":-1.263593,"twenty":-6.650896,"median":-1.724535,"eighty":-1.003608,"marketCap":116960658},{"date":"2023-03-24","current":-1.271555,"twenty":-6.614943,"median":-1.712882,"eighty":-1.003608,"marketCap":117697651},{"date":"2023-03-31","current":-1.115497,"twenty":-6.58752,"median":-1.706572,"eighty":-1.003608,"marketCap":103252604},{"date":"2023-04-06","current":-1.006415,"twenty":-6.558262,"median":-1.70123,"eighty":-1.003608,"marketCap":93155811},{"date":"2023-04-14","current":-1.267176,"twenty":-6.511634,"median":-1.689578,"eighty":-1.003608,"marketCap":117292305},{"date":"2023-04-21","current":-1.313754,"twenty":-6.476846,"median":-1.677925,"eighty":-1.003608,"marketCap":121603709},{"date":"2023-04-28","current":-1.816166,"twenty":-6.406216,"median":-1.672099,"eighty":-1.003608,"marketCap":168107916},{"date":"2023-05-05","current":-1.867678,"twenty":-6.339804,"median":-1.672099,"eighty":-1.003608,"marketCap":172875966},{"date":"2023-05-12","current":-3.496998,"twenty":-6.287227,"median":-1.672099,"eighty":-1.003608,"marketCap":197083808},{"date":"2023-05-19","current":-3.59597,"twenty":-6.265484,"median":-1.672099,"eighty":-1.003608,"marketCap":202661651},{"date":"2023-05-26","current":-3.991856,"twenty":-6.235441,"median":-1.672099,"eighty":-1.003608,"marketCap":224973026},{"date":"2023-06-02","current":-3.59597,"twenty":-6.198802,"median":-1.672099,"eighty":-1.003608,"marketCap":202661651},{"date":"2023-06-09","current":-4.123818,"twenty":-6.128969,"median":-1.672099,"eighty":-1.003608,"marketCap":232410151},{"date":"2023-06-16","current":-3.760922,"twenty":-6.074061,"median":-1.672099,"eighty":-1.003608,"marketCap":211958057},{"date":"2023-06-23","current":-3.464007,"twenty":-5.893888,"median":-1.672099,"eighty":-1.003608,"marketCap":195224527},{"date":"2023-06-30","current":-3.052945,"twenty":-5.838148,"median":-1.672099,"eighty":-1.003608,"marketCap":172057883},{"date":"2023-07-07","current":-2.86259,"twenty":-5.815818,"median":-1.672099,"eighty":-1.003608,"marketCap":161329830},{"date":"2023-07-14","current":-3.59597,"twenty":-5.72283,"median":-1.672099,"eighty":-1.003608,"marketCap":202661651},{"date":"2023-07-21","current":-4.057837,"twenty":-5.625665,"median":-1.672099,"eighty":-1.003608,"marketCap":228691588},{"date":"2023-07-28","current":-5.014563,"twenty":-5.304804,"median":-1.672099,"eighty":-1.003608,"marketCap":282610743},{"date":"2023-08-04","current":-4.981572,"twenty":-5.234042,"median":-1.672099,"eighty":-1.003608,"marketCap":280751462},{"date":"2023-08-11","current":-4.84961,"twenty":-5.145515,"median":-1.672099,"eighty":-1.003608,"marketCap":273314337},{"date":"2023-08-18","current":-4.123818,"twenty":-4.981572,"median":-1.672099,"eighty":-1.003608,"marketCap":232410151},{"date":"2023-08-25","current":-4.123818,"twenty":-4.946901,"median":-1.672099,"eighty":-1.003608,"marketCap":232410151},{"date":"2023-09-01","current":-2.710982,"twenty":-4.820622,"median":-1.672099,"eighty":-1.003608,"marketCap":261756191},{"date":"2023-09-08","current":-2.35992,"twenty":-4.641914,"median":-1.672099,"eighty":-1.003608,"marketCap":227859706},{"date":"2023-09-15","current":-2.415804,"twenty":-4.399189,"median":-1.672099,"eighty":-1.003608,"marketCap":237275396},{"date":"2023-09-22","current":-2.224073,"twenty":-4.351029,"median":-1.672099,"eighty":-1.003608,"marketCap":218444016},{"date":"2023-09-29","current":-2.147381,"twenty":-4.294424,"median":-1.672099,"eighty":-1.003608,"marketCap":210911463},{"date":"2023-10-06","current":-1.974824,"twenty":-4.156809,"median":-1.672099,"eighty":-1.003608,"marketCap":193963221},{"date":"2023-10-13","current":-1.783093,"twenty":-4.156782,"median":-1.672099,"eighty":-1.003608,"marketCap":175131840},{"date":"2023-10-20","current":-1.599607,"twenty":-4.123818,"median":-1.667444,"eighty":-1.003608,"marketCap":157110209},{"date":"2023-10-27","current":-1.577558,"twenty":-4.057837,"median":-1.665773,"eighty":-1.002121,"marketCap":154944600},{"date":"2023-11-03","current":-1.693938,"twenty":-4.027151,"median":-1.661425,"eighty":-1.002121,"marketCap":166375248},{"date":"2023-11-10","current":-2.816876,"twenty":-3.991803,"median":-1.661425,"eighty":-1.002121,"marketCap":171384395},{"date":"2023-11-17","current":-3.178609,"twenty":-3.956521,"median":-1.661425,"eighty":-1.002121,"marketCap":186298292},{"date":"2023-11-24","current":-3.214288,"twenty":-3.908305,"median":-1.661425,"eighty":-1.002121,"marketCap":188389415},{"date":"2023-12-01","current":-3.407145,"twenty":-3.863722,"median":-1.661425,"eighty":-1.002121,"marketCap":199692779},{"date":"2023-12-08","current":-3.760717,"twenty":-3.822295,"median":-1.661919,"eighty":-1.002865,"marketCap":220415615},{"date":"2023-12-15","current":-3.632145,"twenty":-3.794682,"median":-1.661919,"eighty":-1.002865,"marketCap":212880038},{"date":"2023-12-22","current":-3.857146,"twenty":-3.78479,"median":-1.661919,"eighty":-1.002865,"marketCap":226067298},{"date":"2023-12-29","current":-4.114289,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":241138451},{"date":"2024-01-05","current":-4.885718,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":286351910},{"date":"2024-01-12","current":-4.982146,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":292003593},{"date":"2024-01-19","current":-4.500003,"twenty":-3.773404,"median":-1.660689,"eighty":-1.000634,"marketCap":263745181},{"date":"2024-01-26","current":-4.821432,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":282584122},{"date":"2024-02-02","current":-5.496432,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":322145899},{"date":"2024-02-09","current":-5.239289,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":307074746},{"date":"2024-02-16","current":-4.725003,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":276932440},{"date":"2024-02-23","current":-4.46786,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":261861286},{"date":"2024-03-01","current":-5.078575,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":297655275},{"date":"2024-03-08","current":-4.69286,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":275048545},{"date":"2024-03-15","current":-4.970505,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":258093498},{"date":"2024-03-22","current":-8.225699,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":427119441},{"date":"2024-03-28","current":-9.032141,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":468993896},{"date":"2024-04-05","current":-6.08863,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":316152135},{"date":"2024-04-12","current":-6.169275,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":320339580},{"date":"2024-04-19","current":-5.604766,"twenty":-3.777556,"median":-1.660931,"eighty":-1.001378,"marketCap":291027462},{"date":"2024-04-26","current":-5.362833,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":278465125},{"date":"2024-05-03","current":-5.241867,"twenty":-3.781743,"median":-1.661425,"eighty":-1.002121,"marketCap":272183957},{"date":"2024-05-10","current":-6.470817,"twenty":-3.785606,"median":-1.661425,"eighty":-1.002121,"marketCap":278465125},{"date":"2024-05-17","current":-5.546414,"twenty":-3.820207,"median":-1.661425,"eighty":-1.002121,"marketCap":238684393},{"date":"2024-05-24","current":-5.308827,"twenty":-3.825763,"median":-1.661425,"eighty":-1.002121,"marketCap":228460052},{"date":"2024-05-31","current":-5.454941,"twenty":-3.857146,"median":-1.661425,"eighty":-1.002121,"marketCap":234747943},{"date":"2024-06-07","current":-5.162712,"twenty":-3.898025,"median":-1.661425,"eighty":-1.002121,"marketCap":222172160},{"date":"2024-06-14","current":-5.211417,"twenty":-3.952728,"median":-1.661425,"eighty":-1.002121,"marketCap":224268124},{"date":"2024-06-21","current":-4.43214,"twenty":-3.964622,"median":-1.660931,"eighty":-1.001378,"marketCap":190732703},{"date":"2024-06-28","current":-4.967893,"twenty":-4.017268,"median":-1.660931,"eighty":-1.001378,"marketCap":213788305},{"date":"2024-07-05","current":-4.557311,"twenty":-4.034791,"median":-1.660931,"eighty":-1.001378,"marketCap":196119330},{"date":"2024-07-12","current":-6.136809,"twenty":-4.087355,"median":-1.660931,"eighty":-1.001378,"marketCap":264091436},{"date":"2024-07-19","current":-6.575152,"twenty":-4.123818,"median":-1.660931,"eighty":-1.001378,"marketCap":282955110},{"date":"2024-07-26","current":-7.013496,"twenty":-4.156809,"median":-1.660931,"eighty":-1.001378,"marketCap":301818784},{"date":"2024-08-02","current":-6.088104,"twenty":-4.166249,"median":-1.660931,"eighty":-1.001378,"marketCap":261995472},{"date":"2024-08-09","current":-5.77172,"twenty":-4.291514,"median":-1.660931,"eighty":-1.001378,"marketCap":233419913},{"date":"2024-08-16","current":-7.487637,"twenty":-4.338028,"median":-1.660931,"eighty":-1.001378,"marketCap":302815022},{"date":"2024-08-23","current":-7.955614,"twenty":-4.397249,"median":-1.660931,"eighty":-1.001378,"marketCap":321740961},{"date":"2024-08-30","current":-8.059609,"twenty":-4.447291,"median":-1.660931,"eighty":-1.001378,"marketCap":325946725},{"date":"2024-09-06","current":-7.01966,"twenty":-4.500003,"median":-1.660931,"eighty":-1.001378,"marketCap":283889083},{"date":"2024-09-13","current":-7.591632,"twenty":-4.554205,"median":-1.660931,"eighty":-1.001378,"marketCap":307020786},{"date":"2024-09-20","current":-7.123655,"twenty":-4.582713,"median":-1.660931,"eighty":-1.001378,"marketCap":288094847},{"date":"2024-09-27","current":-6.915665,"twenty":-4.628575,"median":-1.660931,"eighty":-1.001378,"marketCap":279683319},{"date":"2024-10-04","current":-6.915665,"twenty":-4.685982,"median":-1.660931,"eighty":-1.001378,"marketCap":279683319},{"date":"2024-10-11","current":-6.863667,"twenty":-4.725003,"median":-1.660931,"eighty":-1.001378,"marketCap":277580437},{"date":"2024-10-18","current":-6.967662,"twenty":-4.806445,"median":-1.660931,"eighty":-1.001378,"marketCap":281786201},{"date":"2024-10-25","current":-8.267599,"twenty":-4.84961,"median":-1.660931,"eighty":-1.001378,"marketCap":334358253},{"date":"2024-11-01","current":-8.787574,"twenty":-4.918657,"median":-1.660931,"eighty":-1.001378,"marketCap":355387074},{"date":"2024-11-08","current":-9.203156,"twenty":-4.96946,"median":-1.660931,"eighty":-1.001378,"marketCap":423271531},{"date":"2024-11-15","current":-8.491571,"twenty":-4.992819,"median":-1.666273,"eighty":-1.001378,"marketCap":390544351},{"date":"2024-11-22","current":-8.918522,"twenty":-5.034498,"median":-1.672099,"eighty":-1.001378,"marketCap":410180659},{"date":"2024-11-29","current":-9.772423,"twenty":-5.100636,"median":-1.672099,"eighty":-1.001378,"marketCap":449453276},{"date":"2024-12-06","current":-9.724984,"twenty":-5.207146,"median":-1.672099,"eighty":-1.001378,"marketCap":447271464},{"date":"2024-12-13","current":-8.776205,"twenty":-5.21207,"median":-1.672099,"eighty":-1.001378,"marketCap":403635223},{"date":"2024-12-20","current":-8.681327,"twenty":-5.266908,"median":-1.672099,"eighty":-1.001378,"marketCap":399271599},{"date":"2024-12-27","current":-9.250595,"twenty":-5.303575,"median":-1.672099,"eighty":-1.001378,"marketCap":425453343},{"date":"2025-01-03","current":-9.108278,"twenty":-5.317037,"median":-1.672099,"eighty":-1.001378,"marketCap":418907907},{"date":"2025-01-10","current":-8.301816,"twenty":-5.361773,"median":-1.669771,"eighty":-1.000634,"marketCap":381817103},{"date":"2025-01-17","current":-9.819862,"twenty":-5.406236,"median":-1.669771,"eighty":-1.000634,"marketCap":451635088},{"date":"2025-01-24","current":-11.290469,"twenty":-5.4838,"median":-1.669771,"eighty":-1.000634,"marketCap":519271260},{"date":"2025-01-31","current":-10.626324,"twenty":-5.508266,"median":-1.669771,"eighty":-1.000634,"marketCap":488725892},{"date":"2025-02-07","current":-10.151935,"twenty":-5.549464,"median":-1.669771,"eighty":-1.000634,"marketCap":466907772},{"date":"2025-02-14","current":-10.104496,"twenty":-5.604766,"median":-1.669771,"eighty":-1.000634,"marketCap":464725960},{"date":"2025-02-21","current":-8.53901,"twenty":-5.645088,"median":-1.669771,"eighty":-1.000634,"marketCap":392726163},{"date":"2025-02-28","current":-8.776205,"twenty":-5.734293,"median":-1.669771,"eighty":-1.000634,"marketCap":403635223},{"date":"2025-03-07","current":-9.0134,"twenty":-5.787417,"median":-1.667444,"eighty":-0.999891,"marketCap":414544283},{"date":"2025-03-14","current":-7.691719,"twenty":-5.877021,"median":-1.667444,"eighty":-0.999891,"marketCap":533882188},{"date":"2025-03-21","current":-8.016455,"twenty":-5.898105,"median":-1.667444,"eighty":-0.999891,"marketCap":556422151},{"date":"2025-03-28","current":-7.188464,"twenty":-6.007986,"median":-1.667444,"eighty":-0.999891,"marketCap":498951318},{"date":"2025-04-04","current":-6.661561,"twenty":-6.088104,"median":-1.667444,"eighty":-0.999891,"marketCap":462378970},{"date":"2025-04-11","current":-6.20993,"twenty":-6.12159,"median":-1.669771,"eighty":-1.000634,"marketCap":431031244},{"date":"2025-04-17","current":-7.753004,"twenty":-6.166695,"median":-1.669771,"eighty":-1.000634,"marketCap":538135977},{"date":"2025-04-25","current":-8.957354,"twenty":-6.198544,"median":-1.667444,"eighty":-0.999891,"marketCap":621729915},{"date":"2025-05-02","current":-9.240352,"twenty":-6.235441,"median":-1.667444,"eighty":-0.999891,"marketCap":641372848},{"date":"2025-05-09","current":-14.779895,"twenty":-6.267066,"median":-1.667444,"eighty":-0.999891,"marketCap":669721381},{"date":"2025-05-16","current":-15.127657,"twenty":-6.277608,"median":-1.667444,"eighty":-0.999891,"marketCap":685479531},{"date":"2025-05-23","current":-16.402785,"twenty":-6.282923,"median":-1.667444,"eighty":-0.999891,"marketCap":743259415},{"date":"2025-05-30","current":-17.446072,"twenty":-6.301326,"median":-1.667444,"eighty":-0.999891,"marketCap":790533866},{"date":"2025-06-06","current":-21.387377,"twenty":-6.370885,"median":-1.667444,"eighty":-0.999891,"marketCap":969126234},{"date":"2025-06-13","current":-21.155536,"twenty":-6.39811,"median":-1.667444,"eighty":-0.999891,"marketCap":958620801},{"date":"2025-06-20","current":-20.633893,"twenty":-6.459617,"median":-1.666859,"eighty":-0.99937,"marketCap":934983576},{"date":"2025-06-27","current":-21.677179,"twenty":-6.47118,"median":-1.666859,"eighty":-0.99937,"marketCap":982258026},{"date":"2025-07-03","current":-20.981655,"twenty":-6.47118,"median":-1.666859,"eighty":-0.99937,"marketCap":950741726},{"date":"2025-07-11","current":-23.068228,"twenty":-6.480009,"median":-1.666859,"eighty":-0.99937,"marketCap":1045290627},{"date":"2025-07-18","current":-22.488625,"twenty":-6.584893,"median":-1.666859,"eighty":-0.99937,"marketCap":1019027043},{"date":"2025-07-25","current":-22.256783,"twenty":-6.656854,"median":-1.666859,"eighty":-0.99937,"marketCap":1008521610},{"date":"2025-08-01","current":-21.358397,"twenty":-6.739348,"median":-1.666859,"eighty":-0.99937,"marketCap":967813055},{"date":"2025-08-08","current":-21.66796,"twenty":-6.863667,"median":-1.666859,"eighty":-0.99937,"marketCap":790533866},{"date":"2025-08-15","current":-23.909856,"twenty":-6.863667,"median":-1.666859,"eighty":-0.99937,"marketCap":872327175},{"date":"2025-08-22","current":-23.183112,"twenty":-6.915665,"median":-1.666859,"eighty":-0.99937,"marketCap":845812671},{"date":"2025-08-29","current":-22.747066,"twenty":-6.967662,"median":-1.666859,"eighty":-0.99937,"marketCap":829903968},{"date":"2025-09-05","current":-21.947649,"twenty":-7.01966,"median":-1.672099,"eighty":-1.002121,"marketCap":800738014},{"date":"2025-09-12","current":-21.729626,"twenty":-7.111363,"median":-1.675277,"eighty":-1.00626,"marketCap":792783663},{"date":"2025-09-19","current":-21.511603,"twenty":-7.12909,"median":-1.682852,"eighty":-1.008143,"marketCap":784829312},{"date":"2025-09-26","current":-19.694744,"twenty":-7.192434,"median":-1.6925,"eighty":-1.011648,"marketCap":718543052},{"date":"2025-10-03","current":-19.694744,"twenty":-7.263736,"median":-1.70123,"eighty":-1.034653,"marketCap":718543052},{"date":"2025-10-10","current":-21.002882,"twenty":-7.378936,"median":-1.707584,"eighty":-1.038178,"marketCap":766269159},{"date":"2025-10-17","current":-21.220905,"twenty":-7.487637,"median":-1.713909,"eighty":-1.038178,"marketCap":774223510},{"date":"2025-10-24","current":-21.656951,"twenty":-7.65045,"median":-1.730725,"eighty":-1.038178,"marketCap":790132213},{"date":"2025-10-31","current":-15.26161,"twenty":-7.747625,"median":-1.764444,"eighty":-1.040964,"marketCap":556804579},{"date":"2025-11-06","current":-15.406959,"twenty":-7.838707,"median":-1.775386,"eighty":-1.052489,"marketCap":562107480}],"updateTime":1762528791880},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AKBA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561467675","title":"Akebia Therapeutics Inc - Co and IRC Announce Availability of Vafseo Across All IRC Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2561467675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561467675?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:06","pubTimestamp":1755777994,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nFWN3UD0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AKBA","BK4139"],"gpt_icon":0},{"id":"2561823467","title":"Akebia Therapeutics Expands Vafseo Availability Nationwide Across IRC Dialysis Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2561823467","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561823467?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:00","pubTimestamp":1755777654,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics, Inc., a biopharmaceutical company focused on improving the lives of those affected by kidney disease, and Innovative Renal Care  have announced the nationwide availability of Vafseo  across all IRC dialysis clinics. This collaboration marks a significant step in expanding access to Vafseo, an innovative treatment for anemia due to chronic kidney disease  in dialysis patients. Implemented through IRC's extensive network of over 230 dialysis centers across 28 states and Washington, D.C., the treatment is now available for patients meeting FDA-approved criteria. This partnership is expected to significantly increase the adoption of Vafseo, which has been accessible to over 55,000 patients and aims to reach more than 275,000 by the end of Q4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL1rmqDR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210149790.SGD","BK4585","LU0314104364.USD","BK4588","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","AKBA"],"gpt_icon":0},{"id":"1168456993","title":"Stock Track | Akebia Therapeutics Soars 5.48% as Analysts Reaffirm Buy Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1168456993","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168456993?lang=en_us&edition=fundamental","pubTime":"2025-08-08 22:14","pubTimestamp":1754662461,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics (AKBA) stock is soaring 5.48% in pre-market trading on Friday, buoyed by positive analyst ratings from two prominent firms. The biotechnology company, which focuses on developing...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AKBA"],"gpt_icon":0},{"id":"2557561250","title":"Akebia Therapeutics Shares Fall After Reporting Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2557561250","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557561250?lang=en_us&edition=fundamental","pubTime":"2025-08-07 22:00","pubTimestamp":1754575252,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics  shares were down more than 17% in early Thursday trading after the company reported breakeven Q2 net income, swinging from a loss of $0.04 per share a year earlier.Analysts polled by FactSet expected a loss of $0.02.Revenue for the quarter ended June 30 was $62.5 million, up from $43.6 million a year earlier.Analysts surveyed by FactSet expected $47.2 million.The company said it had about $137.3 million in cash and cash equivalents as of June 30.Price: 3.13, Change: -0.66, Percent Change: -17.44","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2557855069","title":"Earnings Flash (AKBA) Akebia Therapeutics Posts Q2 EPS $0.00, vs. FactSet Est of $0.02 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2557855069","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557855069?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:36","pubTimestamp":1754566587,"startTime":"0","endTime":"0","summary":"Earnings Flash (AKBA) Akebia Therapeutics Posts Q2 EPS $0.00, vs. FactSet Est of $0.02 Loss","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AKBA"],"gpt_icon":0},{"id":"2557255044","title":"Akebia Therapeutics Q2 revenue smashes expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2557255044","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557255044?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:35","pubTimestamp":1754566555,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics Q2 revenue smashes expectationsOverviewAkebia Q2 2025 revenue rises to $62.5 mln, beating analyst expectationsNet income for Q2 2025 beats estimates, reaching $0.2 mlnCompany expan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX15F5DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA","DVA"],"gpt_icon":0},{"id":"1143714089","title":"Stock Track | Akebia Therapeutics Plunges 20.74% Pre-market Despite Beating Q2 Earnings Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1143714089","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143714089?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:08","pubTimestamp":1754564923,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics (AKBA) experienced a sharp 20.74% pre-market plunge on Thursday, despite reporting second-quarter 2025 financial results that largely beat analyst estimates. This significant...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AKBA"],"gpt_icon":0},{"id":"2557552610","title":"Akebia Therapeutics Q2 Sales $62.472M Beat $47.637M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2557552610","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557552610?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:03","pubTimestamp":1754564621,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics (NASDAQ:AKBA) reported quarterly sales of $62.472 million which beat the analyst consensus estimate of $47.637 million by 31.14 percent.  This is a 43.13 percent increase over sales of $43.648 million","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/46957298/akebia-therapeutics-q2-sales-62-472m-beat-47-637m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA"],"gpt_icon":0},{"id":"2557755422","title":"Akebia Therapeutics Q2 Basic EPS USD 0","url":"https://stock-news.laohu8.com/highlight/detail?id=2557755422","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557755422?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:00","pubTimestamp":1754564404,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX15F5DF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2557554281","title":"Akebia Therapeutics Q2 Net Income USD 247 Thousand VS. Ibes Estimate USD -4.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557554281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557554281?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:00","pubTimestamp":1754564404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX15F5DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2557524885","title":"Akebia Therapeutics Q2 Revenue USD 62.472 Million VS. Ibes Estimate USD 47.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2557524885","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557524885?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:00","pubTimestamp":1754564404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX15F5DF:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2557522565","title":"Akebia Therapeutics Inc - Total Revenues Increase to $62.5 Mln in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557522565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557522565?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:00","pubTimestamp":1754564404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nPLX15F5DF:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2557374310","title":"Akebia Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2557374310","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557374310?lang=en_us&edition=fundamental","pubTime":"2025-08-06 20:00","pubTimestamp":1754481618,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics Inc., a biopharmaceutical company focused on improving the lives of those affected by kidney disease, will participate in a Fireside Chat at Canaccord Genuity's 45th Annual Growth Conference. The event is scheduled for August 13, 2025, at 1:30 PM EDT in Boston.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 06, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nNDL2B4TVt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BGHQF748.EUR","BK4139","AKBA","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2095319765.USD","BK4585","NDAQ","LU2210149790.SGD","BK4588"],"gpt_icon":0},{"id":"2557926583","title":"Akebia Therapeutics Inc  expected to post a loss of 2 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557926583","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557926583?lang=en_us&edition=fundamental","pubTime":"2025-08-05 21:35","pubTimestamp":1754400907,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics Inc  expected to post a loss of2cents a share - Earnings Preview Akebia Therapeutics Inc AKBA.OQ AKBA.O is expected to  show a rise in quarterly revenue when it reports  results on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nL8N3TX1VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA"],"gpt_icon":0},{"id":"2556173389","title":"Akebia Therapeutics Launches VOCAL Trial to Assess Vafseo for Anemia in CKD Patients at DaVita Clinics","url":"https://stock-news.laohu8.com/highlight/detail?id=2556173389","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556173389?lang=en_us&edition=fundamental","pubTime":"2025-08-04 20:01","pubTimestamp":1754308873,"startTime":"0","endTime":"0","summary":"Akebia Therapeutics, Inc. has announced the initiation of the VOCAL trial, a post-marketing study conducted in collaboration with DaVita dialysis clinics. This open-label, active-controlled study aims to evaluate the benefits of administering Vafseo  three times a week for patients with anemia due to chronic kidney disease  undergoing in-center hemodialysis. The trial will enroll approximately 350 patients across 18 DaVita clinics, using a 1:1 randomization process. Participants will be involved in the study for up to 33 weeks, which includes screening, treatment, and safety follow-up. The primary endpoint is the change in hemoglobin levels, while secondary endpoints include the incidence of treatment-emergent serious adverse events and the proportion of patients within the target hemoglobin range, among others. Additionally, a sub-study involving 28 patients will analyze blood samples to understand Vafseo's impact on red blood cell phenotypes. Results from this study have not yet been","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL3LLhS8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU0314104364.USD","BK4196","BK4559","IE00BKPKM429.USD","DVA","LU2095319765.USD","NDAQ","BK4588","IE00B64PRP62.GBP","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","AKBA","BK4112"],"gpt_icon":0},{"id":"2555388038","title":"Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2555388038","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555388038?lang=en_us&edition=fundamental","pubTime":"2025-07-31 20:00","pubTimestamp":1753963200,"startTime":"0","endTime":"0","summary":"Akebia to Host Conference Call on August 7, 2025, at 8:00 a.m. EDTCAMBRIDGE, Mass., July  31, 2025  (GLOBE NEWSWIRE) -- Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced plans to release its fi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/31/3124946/37519/en/Akebia-Therapeutics-to-Report-Second-Quarter-2025-Financial-Results-and-Discuss-Recent-Business-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2548880563","title":"Akebia Therapeutics Inc. SVP, CFO, CBO & Treasurer Erik Ostrowski Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2548880563","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548880563?lang=en_us&edition=fundamental","pubTime":"2025-07-02 05:02","pubTimestamp":1751403739,"startTime":"0","endTime":"0","summary":"Erik Ostrowski, serving as SVP, CFO, CBO & Treasurer, reported a disposal of common shares of Akebia Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL4YtTl3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2548882478","title":"BRIEF-Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548882478","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548882478?lang=en_us&edition=fundamental","pubTime":"2025-07-02 04:12","pubTimestamp":1751400773,"startTime":"0","endTime":"0","summary":"BRIEF-Akebia Therapeutics Reports Inducement Grants UnderNasdaq Listing Rule 5635(C)(4)July 1 (Reuters) - Akebia Therapeutics Inc AKBA.O:AKEBIA THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LIST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA2HRMF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA","BK4139"],"gpt_icon":0},{"id":"2542530460","title":"Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2542530460","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542530460?lang=en_us&edition=fundamental","pubTime":"2025-06-12 05:14","pubTimestamp":1749676474,"startTime":"0","endTime":"0","summary":"Richard C. Malabre, SVP and Chief Accounting Officer of Akebia Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL96Ml0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AKBA"],"gpt_icon":0},{"id":"2541006361","title":"Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2541006361","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541006361?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:35","pubTimestamp":1749155733,"startTime":"0","endTime":"0","summary":"Richard C. Malabre, SVP, Chief Accounting Officer of Akebia Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akebia Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL354z7y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Richard C. Malabre, SVP and Chief Accounting Officer, Reports Disposal of Common Shares of Akebia Therapeutics Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AKBA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":42,"code":"91000000","status":"200"}]}}